Table 1.

Patient and treatment characteristics

Age
Median		48 years
Range		26 – 71 years
Sex
Male		15 (56%)
Female		12 (44%)
Education
Median		15 years
Range		8 – 18 years
Tumor Pathology
Pituitary Adenoma		9 (33%)
Low-Grade Glioma		8 (30%)
Meningioma		6 (22%)
Other		4 (15%)
Tumor Laterality
Midline		13 (48%)
Right		9 (33%)
Right		5 (19%)
Tumor Location
Pituitary		11 (41%)
Frontal Lobe		6 (22%)
Temporal Lobe		5 (19%)
Parietal Lobe		3 (11%)
Occipital Lobe		1 (4%)
Cerebellum		1 (4%)
Treatment Planning
3D-CRT		19 (70%)
IMRT		8 (30%)
Prescription Dose
Median		54 Gy
Range		50.4 – 70 Gy
Whole-brain gEUD
Median		40.46 Gy
Range		32.57 – 52.82 Gy
Pre-RT Surgery
Full or Partial Resection		23 (85%)
None		3 (11%)
Biopsy Only		1 (4%)
Concurrent Chemotherapy
None		23 (85%)
Temozolomide		4 (15%)
Imaging System
Philips Achieva 3T		15 (56%)
GE Signa 1.5T		9 (33%)
Siemens Skyra 3T		3 (11%)